Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancer. Al-Khanaty A, Chen D, Walbaum J, Hennes D, et al. BJU Int 2026 Apr 14. doi: 10.1111/bju.70283.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Al-Khanaty A, Chen D, Walbaum J, Hennes D, et al. Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancer. BJU Int 2026 Apr 14. doi: 10.1111/bju.70283.
PMID: 41979224